Delivery Order 75A50122D00002-75A50123F61006
Award Date
2/22/23
Potential Completion Date
2/21/24
Potential Value
$2M
Awardee
Glaxosmithkline, LLC
Ultimate Awardee
Not listed
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Research Triangle Park, NC 27709, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The purpose of this $7,401,821.12 firm-fixed-price task order is to procure storage and stability services for antigens and adjuvants from prior contracts during the 3rd year of the base period of an Indefinite Delivery, Indefinite Quantity (IDIQ) contract with the identifier 75A50122D000002....
This federal contract award was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a component of the U.S. Department of Health and Human Services (HHS), to Glaxosmithkline, LLC. The purpose of this delivery order task order is to procure services for storage and stability of vaccine bulk lots from prior contracts for HHS under an Indefinite Delivery, Indefinite Quantity (IDIQ) contract worth up to $2,261,160.70. The contract is a firm fixed-price arrangement...
This federal contract award is for the manufacture of one bulk lot of the antigen AS03 on behalf of the Department of Defense Defense Health Agency. The contract was awarded to Glaxosmithkline, LLC, a pharmaceutical company that has provided a range of pharmaceutical goods and services to U.S. government agencies through various federal contracts and grants. The $8,359,043 firm fixed price delivery order is issued under the Pandemic Influenza Preparedness and Response 2016-2021 indefinite...
This federal contract award from the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response (ASPR) was issued to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The contract, valued at $1,811,664.60, is a delivery order under the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract....
This federal contract award to Glaxosmithkline, LLC, doing business as Glaxosmithkline, is for the storage and stability testing of bulk lots and final containers of COVID-19 vaccine adjuvant (AS03) on behalf of the U.S. Department of Health and Human Services (HHS), Office of the Assistant Secretary for Preparedness and Response. The $14,047,403.70 firm fixed price delivery order, which has no set-aside designation, has a performance period through May 21, 2027. Glaxosmithkline, a foreign-owned...
<p>This is a firm fixed-price delivery order awarded to Glaxosmithkline, LLC by the Office of the Assistant Secretary for Preparedness and Response, a civilian agency, under IDIQ contract 75A50122D00002. The purpose is to procure services for storage and stability of vaccine bulk lots for the U.S. Department of Defense during the third year of the base period. The award ceiling is $312,168.64 and the ultimate completion date is May 21, 2027. The contract has no set-aside designation.</p>
This $563,504 firm fixed price delivery order was awarded by the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) to Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other pharmaceutical products to U.S. government agencies. The order is part of the Pandemic Influenza Preparedness and Response 2016-2021 indefinite delivery, indefinite quantity (IDIQ) contract and does not have a...
This is a delivery order issued under the Department of Health and Human Services (HHS) Office of the Assistant Secretary for Preparedness and Response (ASPR) Pandemic Influenza Preparedness and Response 2016-2021 contract vehicle. The $2,064,652.60 firm fixed price contract was awarded to Glaxosmithkline, LLC to provide a range of pharmaceutical goods and services, including influenza vaccines, antiviral medications, vaccine adjuvants, and COVID-19 treatments. Glaxosmithkline, a foreign-owned...
This federal contract award, valued at $22,877,697.00, was issued by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian agency within the U.S. Department of Health and Human Services (HHS). The purpose of this Delivery Order is to procure an Influenza A/Astrakhan/3212/2020 (H5N8) virus vaccine candidate and conduct the associated clinical trial. This award was made to the prime contractor, Glaxosmithkline, LLC, a foreign-owned, for-profit pharmaceutical...
This delivery order against the Department of Defense's IDIQ contract 75A50122D00002 tasks Glaxosmithkline, LLC to provide storage and stability services for vaccine bulk lots procured under prior contracts. Valued at $62,952 and set for performance in Research Triangle Park, North Carolina through February 2023, the firm fixed price order supports the Department of Health and Human Services Office of the Assistant Secretary for Preparedness and Response. As the prime contractor, Glaxosmithkline...